4.5 years at McKinsey&Company as Engagement manager with experience in manufacturing, sourcing, strategy
PhD, Environmental Eng., Cornell University
Diplôme d’ingénieur, Ecole Centrale Paris
DR. CESARE CEJAS
Founder, Head of Microfluidics
5 years experience in microfabrication, microfluidic system design and engineering, prototyping and testing at the Microfluidics, MEMS, and Nanostructures Lab at Ecole Supérieure de Physique et Chimie Industrielle (ESPCI Paris)
PhD from Pierre et Marie Curie University in Materials Science (Physics and Chemistry)
Post-doctoral researcher for Sanofi (Pharmaceutical Sciences Dept. - Early Development)
DR. JAMES KUSENA
Head of Bioprocessing
Experience and PhD in human pluripotent stem cell culture and differentiation from Loughborough University.
Experience in cell therapy process development and manufacturing optimisation.
Background in Medicinal Chemistry, International Business and Health economics.
DR. JIM MILLS
20 years experience of working in the biopharma sectofr with expertise in all areas of bioprocess development; upstream process, downstream process and analytical development.
Ex-CEO of Cantab, ex-SVP TEchnical Operations at Abzena
DR. TOBY KING
Chairman and interim COO
25 years of experience in technology development, particularly in small organisations working in highly regulated environments, with several CTO/COO/CEO/Chairman roles
PhD in Mechanical Engineering applied to medical devices from Cambridge University
25+ years of experience in medical device design and development
25+ years of project and multi disciplinary team management in small and large companies (Baxter, blood transfusion systems, Cardio Life Research, cardiac surgery acquired by St Jude Medical)
8 years of consulting mostly for medtech start-ups (bariatric surgery, assisted reproductive treatment, hematology..)
DR. PAUL SIMMONS
Head of Research and Product development at Mesoblast
30+ years of experience in stem cell research
Past president of International Society of Stem Cell Research (ISSCR), C. Harold and Lorine G. Wallace Distinguished Univ.
Chair at the Univ. of Texas Health Institute, Inaugural Professor and Director, Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine
Non-executive director at Mesoblast since 2004
15 years board experience for various Australian and international biotechnologies companies
Ex-PwC partner and director
PROF. TREVOR JONES
Director of the drug discovery company, e-Therapeutics plc and the life science investment company Arix Bioscience Plc.
Boards as Director in the UK: NextPharma Ltd, ReNeuron,BAC BV, Sigma-Tau Finanziaria, Tecnogen SpA, SciClone Inc,and President of Sigma-Tau Pharmaceuticals Inc